Luxturna success in Ireland
A 31-year-old Irishman can read again after becoming the country’s first patient to receive Luxturna to treat RPE65-inherited retinal dystrophy.
Staff reporters2 min read
Ophthalmology News
Shingles vaccine linked to reduced dementia risk
A recent study of more than 280,000 people in Wales found the live-attenuated varicella zoster virus vaccine (Zostavax) reduced their risk of a new dementia diagnosis by 20% over a seven-year period.
Staff reporters2 min read
Age affects uveitis impact
A team of New Zealand researchers has shown that age appears to be a key factor influencing the underlying aetiology and clinical course of uveitis. Published in the American Journal of Ophthalmolog
Staff reporters2 min read
ANZGS Congress goes off with a bang!
Sandwiched between the brutalist concrete blocks of the Western Australia Commonwealth Court and the Perth Concert Hall, the Duxton Hotel was the setting for the 2025 Australian and New Zealand Glauco
Dr Graham Reeves6 min read
Myopia interventions compared
A literature review comparing repeated low-level red light (RLRL) therapy with single vision spectacles (SVS) found RLRL treatment led to “considerable reductions” in both axial length (AL) and spheri
Staff reporters2 min read
Alcon’s war on waste
Alcon is cutting back on packaging material manufacturing and reducing waste going to NZ landfills.
Susanne Bradley4 min read
Concern over repeal of Therapeutic Products Act
The Therapeutics Products Act (TPA) 2023 has been repealed, despite being hailed by now-former health minister Dr Ayesha Verrall as the most significant change to the regulation of medicines, medical devices and natural health products in New Zealand in nearly 40 years.
Staff reporters2 min read
Southern Vision Bus canned
BLVNZ is pulling the plug on its joint venture with Rotary to fund and operate a Southern Vision Bus.
Susanne Bradley2 min read
CDR-Life’s GA therapy advances
CDR-Life is recruiting for phase 2 clinical trials of its novel antibody fragment-based therapy for geographic atrophy (GA), following favourable phase 1 safety results.
Staff reporters1 min read
Novel therapy repairs ‘irreversible’ corneal damage
A groundbreaking, experimental stem cell treatment for blinding cornea injuries resulted in a 92% success rate at 18 months.
Staff reporters2 min read
AI accelerator for drug research unveiled
An Australian research team has developed a large language model (LLM) designed to speed up scientific discovery in molecular property prediction. Lead co-author, PhD candidate Yizhen Zheng, from Mo
Staff reporters1 min read
Middle-aged retinas reveal Alzheimer’s risk
An international team including New Zealand researchers found measures of retinal health captured the risk of Alzheimer's disease and related dementias (ADRD) across several domains of known risk fact
Staff reporters1 min read